High-dose intravenous immunoglobulin therapy for scleromyxoedema: a prospective open-label clinical trial using an objective score of clinical evaluation system

2017 ◽  
Vol 31 (7) ◽  
pp. 1157-1160 ◽  
Author(s):  
A. Guarneri ◽  
M. Cioni ◽  
F. Rongioletti
Keyword(s):  
Clinical Trial ◽  
Intravenous Immunoglobulin ◽  
Clinical Evaluation ◽  
Evaluation System ◽  
Immunoglobulin Therapy ◽  
High Dose ◽  
Open Label ◽  
Intravenous Immunoglobulin Therapy ◽  
Objective Score

High-dose intravenous immunoglobulin therapy for myasthenia gravis

1997 ◽  
Vol 245 (1) ◽  
pp. 26-31 ◽  
Author(s):  
J. L. M. Jongen ◽  
P. A. van Doorn ◽  
Frans G. A. van der Meché
Keyword(s):  
Myasthenia Gravis ◽  
Intravenous Immunoglobulin ◽  
Immunoglobulin Therapy ◽  
High Dose ◽  
Intravenous Immunoglobulin Therapy

Cerebral infarction after high-dose intravenous immunoglobulin therapy for Kawasaki disease

2006 ◽  
Vol 148 (3) ◽  
pp. 399-400 ◽  
Author(s):  
Yasunori Wada ◽  
Atsushi Kamei ◽  
Yukiharu Fujii ◽  
Ken Ishikawa ◽  
Shoichi Chida
Keyword(s):  
Kawasaki Disease ◽  
Cerebral Infarction ◽  
Intravenous Immunoglobulin ◽  
Immunoglobulin Therapy ◽  
High Dose ◽  
Intravenous Immunoglobulin Therapy
Sign in / Sign up

Export Citation Format

Share Document